BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2425057)

  • 1. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages.
    Sutherland JA; Turner AR; Mannoni P; McGann LE; Turc JM
    J Biol Response Mod; 1986 Jun; 5(3):250-62. PubMed ID: 2425057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
    Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
    Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of B-lymphocyte antigens on the chronic myeloid leukemic cell line K562 using sodium butyrate.
    Fraser JK; Berridge MV
    Exp Hematol; 1987 May; 15(4):406-13. PubMed ID: 2952519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class-I and class-II antigen expression by human leukemic K562 cells and by Burkitt-K562 hybrids: modulation by differentiation inducers and interferon.
    Garson D; Dokhélar MC; Wakasugi H; Mishal Z; Tursz T
    Exp Hematol; 1985 Oct; 13(9):885-90. PubMed ID: 3930277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
    Santoli D; Francis MK; Matera L; Ferrero D
    J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
    Green AR; Rockman S; DeLuca E; Begley CG
    Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human promyelocytic HL60 cell line: a model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate.
    Ahmed N; Williams JF; Weidemann MJ
    Biochem Int; 1991 Feb; 23(3):591-602. PubMed ID: 1652248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the K562 cell sensitivity to nonspecific lysis by human and rat leukocytes under the influence of sodium butyrate, dimethyl sulfoxide and phorbol-12-myristate-13-acetate].
    Anisimov AG; Bolotnikov IA; Volkova TO
    Ontogenez; 2000; 31(1):47-52. PubMed ID: 10732363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K562 erythroleukemia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation.
    Järvinen M; Andersson LC; Virtanen I
    J Cell Physiol; 1990 May; 143(2):310-20. PubMed ID: 1692028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells.
    Fioritoni G; Bertolini L; Torlontano G; Revoltella R
    Cancer Res; 1980 Mar; 40(3):866-72. PubMed ID: 6937242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens.
    Rowley PT; Farley BA; LaBella S; Giuliano R; Leary JF
    Int J Cell Cloning; 1992 Jul; 10(4):232-40. PubMed ID: 1645031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells.
    Tsao D; Morita A; Bella A; Luu P; Kim YS
    Cancer Res; 1982 Mar; 42(3):1052-8. PubMed ID: 7059970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
    Stöckbauer P; Malasková V; Soucek J; Chudomel V
    Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
    Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
    Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron deprivation blocks multilineage haematopoietic differentiation by inhibiting induction of p21(WAF1/CIP1).
    Alcantara O; Boldt DH
    Br J Haematol; 2007 May; 137(3):252-61. PubMed ID: 17408467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of a hematopoietic-specific differentiation antigen of K562 cells in the human myeloid and lymphoid cell lineages.
    Clarke BJ; Liao SK; Leeds C; Soamboonsrup P; Neame PB
    Cancer Res; 1987 Aug; 47(16):4254-9. PubMed ID: 3475169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in insulin receptor expression accompanying differentiation of HL-60 leukemia cells.
    Chaplinski TJ; Bennett TE; Caro JF
    Cancer Res; 1986 Mar; 46(3):1203-7. PubMed ID: 3002611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.